Polar Asset Management Partners’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-75,300
| Closed | -$1.99M | – | 750 |
|
|
2024
Q2 | $1.99M | Buy |
75,300
+23,800
| +46% | +$628K | 0.04% | 307 |
|
|
2024
Q1 | $1.66M | Buy |
51,500
+39,400
| +326% | +$1.27M | 0.03% | 367 |
|
|
2023
Q4 | $510K | Sell |
12,100
-143,400
| -92% | -$6.04M | 0.01% | 434 |
|
|
2023
Q3 | $5.97M | Buy |
155,500
+500
| +0.3% | +$19.2K | 0.13% | 185 |
|
|
2023
Q2 | $2.94M | Sell |
155,000
-373,000
| -71% | -$7.08M | 0.05% | 389 |
|
|
2023
Q1 | $8.19M | Hold |
528,000
| – | – | 0.12% | 186 |
|
|
2022
Q4 | $9.37M | Buy |
+528,000
| New | +$9.37M | 0.11% | 231 |
|
|
2022
Q2 | – | Sell |
-348,400
| Closed | -$1.92M | – | 1346 |
|
|
2022
Q1 | $1.92M | Hold |
348,400
| – | – | 0.02% | 614 |
|
|
2021
Q4 | $2.97M | Buy |
348,400
+237,600
| +214% | +$2.02M | 0.03% | 493 |
|
|
2021
Q3 | $963K | Buy |
+110,800
| New | +$963K | 0.01% | 629 |
|